ENTA - Enanta Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts6466
Avg. Estimate1.151.213.322.06
Low Estimate1.0313.190.62
High Estimate1.311.393.394.13
Year Ago EPS1.860.590.913.32
Revenue EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts6366
Avg. Estimate68.01M66.14M207.36M208.62M
Low Estimate67M58.38M206M163.57M
High Estimate70.8M72M210.22M260M
Year Ago Sales75.93M38.11M102.81M207.36M
Sales Growth (year/est)-10.40%73.60%101.70%0.60%
Earnings History9/29/201712/30/20173/30/20186/29/2018
EPS Est.2.130.190.530.98
EPS Actual1.860.590.610.97
Difference-0.270.40.08-0.01
Surprise %-12.70%210.50%15.10%-1.00%
EPS TrendCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Current Estimate1.151.213.322.06
7 Days Ago1.151.213.322.06
30 Days Ago1.151.213.322.06
60 Days Ago1.090.753.263.71
90 Days Ago1.120.753.253.29
EPS RevisionsCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesENTAIndustrySectorS&P 500
Current Qtr.-38.20%N/AN/A0.32
Next Qtr.105.10%N/AN/A0.43
Current Year264.80%N/AN/A0.24
Next Year-38.00%N/AN/A0.27
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)-28.34%N/AN/AN/A